annual CFO:
$213.39M+$29.88M(+16.28%)Summary
- As of today (June 28, 2025), AMPH annual cash flow from operations is $213.39 million, with the most recent change of +$29.88 million (+16.28%) on December 31, 2024.
- During the last 3 years, AMPH annual CFO has risen by +$115.39 million (+117.75%).
- AMPH annual CFO is now at all-time high.
Performance
AMPH Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$35.08M+$6.05M(+20.86%)Summary
- As of today (June 28, 2025), AMPH quarterly cash flow from operations is $35.08 million, with the most recent change of +$6.05 million (+20.86%) on March 31, 2025.
- Over the past year, AMPH quarterly CFO has dropped by -$20.21 million (-36.56%).
- AMPH quarterly CFO is now -49.24% below its all-time high of $69.11 million, reached on June 30, 2024.
Performance
AMPH quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$193.17M-$20.21M(-9.47%)Summary
- As of today (June 28, 2025), AMPH TTM cash flow from operations is $193.17 million, with the most recent change of -$20.21 million (-9.47%) on March 31, 2025.
- Over the past year, AMPH TTM CFO has dropped by -$5.24 million (-2.64%).
- AMPH TTM CFO is now -9.47% below its all-time high of $213.39 million, reached on December 31, 2024.
Performance
AMPH TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AMPH Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.3% | -36.6% | -2.6% |
| 3 y3 years | +117.8% | -30.9% | +53.4% |
| 5 y5 years | +411.0% | +2274.9% | +312.3% |
AMPH Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +139.3% | -49.2% | +1146.1% | -9.5% | +145.2% |
| 5 y | 5-year | at high | +411.0% | -49.2% | +2274.9% | -9.5% | +666.1% |
| alltime | all time | at high | >+9999.0% | -49.2% | +392.2% | -9.5% | >+9999.0% |
AMPH Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $35.08M(+20.9%) | $193.17M(-9.5%) |
| Dec 2024 | $213.39M(+16.3%) | $29.02M(-51.6%) | $213.39M(+2.5%) |
| Sep 2024 | - | $59.96M(-13.2%) | $208.23M(-2.1%) |
| Jun 2024 | - | $69.11M(+25.0%) | $212.60M(+7.1%) |
| Mar 2024 | - | $55.29M(+131.7%) | $198.41M(+8.1%) |
| Dec 2023 | $183.50M(+105.8%) | $23.86M(-62.9%) | $183.50M(+4.9%) |
| Sep 2023 | - | $64.33M(+17.1%) | $174.87M(+33.6%) |
| Jun 2023 | - | $54.92M(+36.0%) | $130.91M(+66.1%) |
| Mar 2023 | - | $40.38M(+165.2%) | $78.80M(-11.6%) |
| Dec 2022 | $89.18M(-9.0%) | $15.23M(-25.3%) | $89.18M(-22.0%) |
| Sep 2022 | - | $20.38M(+623.8%) | $114.40M(+18.4%) |
| Jun 2022 | - | $2.81M(-94.5%) | $96.59M(-23.3%) |
| Mar 2022 | - | $50.77M(+25.5%) | $125.93M(+28.5%) |
| Dec 2021 | $97.99M(+71.1%) | $40.44M(+1474.2%) | $97.99M(+31.6%) |
| Sep 2021 | - | $2.57M(-92.0%) | $74.45M(-7.7%) |
| Jun 2021 | - | $32.16M(+40.9%) | $80.68M(+2.6%) |
| Mar 2021 | - | $22.82M(+35.1%) | $78.61M(+37.3%) |
| Dec 2020 | $57.27M(+37.1%) | $16.89M(+91.8%) | $57.27M(+24.4%) |
| Sep 2020 | - | $8.81M(-70.7%) | $46.02M(+82.5%) |
| Jun 2020 | - | $30.09M(+1937.2%) | $25.21M(-46.2%) |
| Mar 2020 | - | $1.48M(-73.9%) | $46.85M(+12.2%) |
| Dec 2019 | $41.76M(+9.4%) | $5.65M(-147.1%) | $41.76M(-8.5%) |
| Sep 2019 | - | -$12.00M(-123.2%) | $45.63M(-37.8%) |
| Jun 2019 | - | $51.72M(-1532.8%) | $73.41M(+180.0%) |
| Mar 2019 | - | -$3.61M(-137.9%) | $26.22M(-31.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $38.19M(-2.6%) | $9.52M(-39.7%) | $38.19M(-0.6%) |
| Sep 2018 | - | $15.78M(+248.1%) | $38.44M(+53.0%) |
| Jun 2018 | - | $4.53M(-45.8%) | $25.13M(-0.2%) |
| Mar 2018 | - | $8.36M(-14.4%) | $25.17M(-35.8%) |
| Dec 2017 | $39.21M(+1.7%) | $9.77M(+295.0%) | $39.21M(-9.8%) |
| Sep 2017 | - | $2.47M(-46.0%) | $43.45M(+2.8%) |
| Jun 2017 | - | $4.57M(-79.6%) | $42.28M(-10.1%) |
| Mar 2017 | - | $22.40M(+59.9%) | $47.03M(+22.0%) |
| Dec 2016 | $38.56M(+261.0%) | $14.01M(+979.0%) | $38.56M(+38.5%) |
| Sep 2016 | - | $1.30M(-86.1%) | $27.84M(-7.5%) |
| Jun 2016 | - | $9.33M(-33.1%) | $30.10M(+29.3%) |
| Mar 2016 | - | $13.93M(+323.8%) | $23.27M(+117.9%) |
| Dec 2015 | $10.68M(-49.3%) | $3.29M(-7.5%) | $10.68M(-45.8%) |
| Sep 2015 | - | $3.55M(+41.9%) | $19.72M(-33.8%) |
| Jun 2015 | - | $2.50M(+87.1%) | $29.79M(+5.6%) |
| Mar 2015 | - | $1.34M(-89.1%) | $28.23M(+34.1%) |
| Dec 2014 | $21.05M(-32.2%) | $12.32M(-9.6%) | $21.05M(+22.1%) |
| Sep 2014 | - | $13.63M(+1359.3%) | $17.24M(+299.1%) |
| Jun 2014 | - | $934.00K(-116.0%) | $4.32M(-81.8%) |
| Mar 2014 | - | -$5.83M(-168.6%) | $23.68M(-23.7%) |
| Dec 2013 | $31.04M(-1981.3%) | $8.51M(+1100.6%) | $31.04M(+37.8%) |
| Sep 2013 | - | $709.00K(-96.5%) | $22.53M(+3.2%) |
| Jun 2013 | - | $20.29M(+1229.0%) | $21.82M(+1329.0%) |
| Mar 2013 | - | $1.53M | $1.53M |
| Dec 2012 | -$1.65M(-108.6%) | - | - |
| Dec 2011 | $19.10M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual CFO year-on-year change?
- What is Amphastar Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly CFO year-on-year change?
- What is Amphastar Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM CFO year-on-year change?
What is Amphastar Pharmaceuticals annual cash flow from operations?
The current annual CFO of AMPH is $213.39M
What is the all time high annual CFO for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual cash flow from operations is $213.39M
What is Amphastar Pharmaceuticals annual CFO year-on-year change?
Over the past year, AMPH annual cash flow from operations has changed by +$29.88M (+16.28%)
What is Amphastar Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AMPH is $35.08M
What is the all time high quarterly CFO for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly cash flow from operations is $69.11M
What is Amphastar Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AMPH quarterly cash flow from operations has changed by -$20.21M (-36.56%)
What is Amphastar Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AMPH is $193.17M
What is the all time high TTM CFO for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM cash flow from operations is $213.39M
What is Amphastar Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AMPH TTM cash flow from operations has changed by -$5.24M (-2.64%)